首页 › 基金 › Lisanti Capital Growth, LLC › GRDN

Lisanti Capital Growth, LLC 对 GRDN 的持仓历史

GUARDIAN PHARMACY SVCS INC · 日常消费

Lisanti Capital Growth, LLC 在 Q3 2026 的 13F 申报中披露持有 GRDN(GUARDIAN PHARMACY SVCS INC)147,435 股,市值约 US$6.0M,约占其申报组合的 1.61%,在其申报持仓中市值排名第 15 位。 Lisanti Capital Growth, LLC 最近 3 个申报季度中有 3 个季度披露了 GRDN 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)147.44K 股
申报持仓市值$6.01M
组合权重1.61%
首次申报Q1 2026
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Lisanti Capital Growth, LLC 对 GRDN 的持仓演变

Lisanti Capital Growth, LLC 于 Q1 2026 首次披露 GRDN 持仓:188,150 股(约 US$7.1M)。 在 3 次申报中,Lisanti Capital Growth, LLC 0 次增持、2 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 147,435 股、市值约 US$6.0M,环比减持 -4,590 股。。

逐季持仓明细

季度股数金额变化
Q1 2026 188.15K $7.09M 新进
Q2 2026 152.03K $6.37M 减持
Q3 2026 147.44K $6.01M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 GRDN 与 13F 数据

GRDN(GUARDIAN PHARMACY SVCS INC)属于日常消费行业。我们追踪的基金中还有 60 只申报持有 GRDN,申报仓位最大的包括:Valiant Capital Management, L.P. (US$49.7M), BOONE CAPITAL MANAGEMENT LLC (US$29.8M), Aristotle Capital Boston, LLC (US$17.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GRDN 的基金

查看 GRDN 的全部基金持有人 →

常见问题

How long has Lisanti Capital Growth, LLC held GRDN?

Lisanti Capital Growth, LLC has disclosed GRDN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Lisanti Capital Growth, LLC's current position in GRDN?

As of Q3 2026, Lisanti Capital Growth, LLC holds 147.44K shares of GRDN (GUARDIAN PHARMACY SVCS INC), valued at $6.01M, representing 1.61% of its reported portfolio and ranking #15.

Has Lisanti Capital Growth, LLC been buying or selling GRDN?

In the latest 13F filing (Q3 2026), Lisanti Capital Growth, LLC reduced its position in GRDN.

Which other funds hold GRDN?

Other major institutional holders of GRDN include Valiant Capital Management, L.P., BOONE CAPITAL MANAGEMENT LLC, Aristotle Capital Boston, LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.